Chalmers Robin L, Hickson-Curran Sheila B, Keay Lisa, Gleason William J, Albright Roger
Clinical Trial Consultant, Atlanta, Georgia, United States.
Director, Medical Affairs, Johnson & Johnson Vision Care, Inc., Jacksonville, Florida, United States.
Invest Ophthalmol Vis Sci. 2015 Jan 8;56(1):654-63. doi: 10.1167/iovs.14-15582.
To report annualized adverse events (AEs) including corneal infiltrative events (CIEs) with use of silicone hydrogel (SiHyDD) and hydrogel daily disposable (HydDD) soft contact lenses (SCLs) in the 1•DAY ACUVUE TruEye or 1•DAY ACUVUE MOIST Performance Overview (TEMPO) Registry (NCT01467557).
Annualized incidence of symptomatic daily disposable (DD)-related AEs was calculated from 3064 surveys from 1171 subjects (601 SiHyDD and 570 HydDD, 31.8 ± 13.5 years, 68% female) during 1 year. Three independent experts adjudicated potential AE cases. Demographics were compared between wearers with and without AEs.
The registry tracked 960.3 years of lens wear: SiHyDD 489.4 years and HydDD 470.9 years. In that period, the 601 SiHyDD wearers reported eight AEs with office visits (1.6%/y; 2 CIEs, 0.4%/y), eight (1.6%/y) without office visits, and four AEs unrelated to SCLs (0.8%/y) (SiHyDD wearers with AEs; 44.8 ± 12.5 years; 75% female). The 570 HyDD wearers reported three AEs with office visits (0.6%/y; no CIEs), five without office visits (1.1%/y), and one non-SCL-related AE (0.2%/y) (HydDD wearers with AEs; 26.3 ± 8.0 years; 100% female). These CIE rates are significantly lower than the lowest estimate of 3.3% from prior studies. Wearers with SiHyDD-related AEs were significantly older than unaffected wearers (P = 0.02), but not for HydDD-related AEs.
The CIE rates of 0.4% and 0% with these DD lenses are significantly lower than rates reported with reusable SCLs (3%-4%/y), indicating improved safety outcomes with these DD lenses. Compared to unaffected wearers, SiHyDD lens wearers with AEs requiring clinical visits were significantly older. (ClinicalTrials.gov number, NCT01467557.).
在1•DAY ACUVUE TruEye或1•DAY ACUVUE MOIST性能概述(TEMPO)注册研究(NCT01467557)中,报告使用硅水凝胶(SiHyDD)和水凝胶日抛型(HydDD)软性接触镜(SCL)的年化不良事件(AE),包括角膜浸润事件(CIE)。
从1171名受试者(601名使用SiHyDD和570名使用HydDD,年龄31.8±13.5岁,68%为女性)的3064份调查问卷中计算出有症状的日抛型(DD)相关AE的年化发病率。三位独立专家对潜在的AE病例进行判定。比较了发生AE和未发生AE的佩戴者的人口统计学特征。
该注册研究追踪了960.3年的镜片佩戴情况:SiHyDD为489.4年,HydDD为470.9年。在此期间,601名使用SiHyDD的佩戴者报告了8例需要就诊的AE(1.6%/年;2例CIE,0.4%/年),8例(1.6%/年)无需就诊,以及4例与SCL无关的AE(0.8%/年)(发生AE的SiHyDD佩戴者;年龄44.8±12.5岁;75%为女性)。570名使用HydDD的佩戴者报告了3例需要就诊的AE(0.6%/年;无CIE),5例无需就诊(1.1%/年),以及1例与SCL无关的AE(0.2%/年)(发生AE的HydDD佩戴者;年龄26.3±8.0岁;100%为女性)。这些CIE发生率显著低于先前研究中最低估计的3.3%。与未受影响的佩戴者相比,发生与SiHyDD相关AE的佩戴者年龄显著更大(P=0.02),但与HydDD相关AE的佩戴者并非如此。
这些日抛型镜片的CIE发生率分别为0.4%和0%,显著低于可重复使用SCL报告的发生率(3% - 4%/年),表明这些日抛型镜片的安全性更高。与未受影响的佩戴者相比,因AE需要临床就诊的SiHyDD镜片佩戴者年龄显著更大。(ClinicalTrials.gov编号,NCT01467557。)